Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5d39fe4cef4ee47ad3c01dcaee17855 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac5ce453d31c1da40a11f093cb801c36 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-136 |
filingDate |
2007-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61c77463f6d9d3352916cd7c4f2dca87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1ee853d957f60253ebec2eafb5e9c0e |
publicationDate |
2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007123900-A3 |
titleOfInvention |
Enantiomers of n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamine borane as intermediates in the synthesis of duloxetine |
abstract |
Duloxetine intermediates of formulae (I) and (II), processes for their preparation, and their conversion to pharmaceutically acceptable salts of duloxetine are described. |
priorityDate |
2006-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |